BVX — Bivictrix Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- £9.49m
- £8.00m
2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | Interim Report | ARS | ARS |
Standards: | — | IFRS | IFRS |
Status: | Final | Final | Final |
Cash | |||
Cash and Short Term Investments | 0.862 | 6.06 | 3.29 |
Net Total Accounts Receivable | |||
Net Total Receivables | 0.143 | 0.26 | 0.565 |
Prepaid Expenses | |||
Total Current Assets | 1 | 6.54 | 3.96 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 0.063 | 0.339 | 0.571 |
Total Assets | 1.07 | 6.88 | 4.54 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Current Liabilities | 0.33 | 0.379 | 0.391 |
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Total Other Liabilities | |||
Total Liabilities | 1 | 0.554 | 0.579 |
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Total Equity | 0.067 | 6.33 | 3.96 |
Total Liabilities & Shareholders' Equity | 1.07 | 6.88 | 4.54 |
Total Common Shares Outstanding |